Ufp Technologies (UFPT) Total Debt (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59% |
| Dec 31, 2025 | -7.30% |
| Sep 30, 2025 | -10.70% |
| Jun 30, 2025 | -10.47% |
| Mar 31, 2025 | -3.50% |
| Dec 31, 2024 | -10.67% |
| Sep 30, 2024 | 502.27% |
| Jun 30, 2024 | 3.53% |
| Mar 31, 2024 | 3.03% |
| Dec 31, 2023 | -23.26% |
| Sep 30, 2023 | -24.56% |
| Jun 30, 2023 | -5.00% |
| Mar 31, 2023 | 9.09% |
| Dec 31, 2022 | -22.54% |
| Sep 30, 2022 | -29.00% |
| Jun 30, 2022 | 5.26% |
| Mar 31, 2022 | 25.76% |
| Sep 30, 2019 | -13.93% |
| Jun 30, 2019 | -21.29% |
| Mar 31, 2019 | -11.93% |
| Dec 31, 2018 | -25.74% |
| Sep 30, 2018 | -14.44% |
| Jun 30, 2018 | 57.38% |
| Sep 30, 2017 | -75.44% |
| Jun 30, 2017 | -43.00% |
| Mar 31, 2017 | -29.91% |
| Dec 31, 2016 | -23.02% |
| Sep 30, 2016 | -18.53% |
| Jun 30, 2016 | -15.69% |
| Mar 31, 2016 | -13.42% |
| Dec 31, 2015 | -11.83% |
| Sep 30, 2015 | -10.51% |
| Jun 30, 2015 | -9.51% |
| Mar 31, 2015 | -8.62% |
| Dec 31, 2014 | -7.90% |
| Sep 30, 2014 | -7.30% |
| Jun 30, 2014 | -6.75% |
| Mar 31, 2014 | -6.32% |
| Dec 31, 2013 | -58.62% |
| Sep 30, 2013 | -3.99% |
| Jun 30, 2013 | -3.82% |
| Mar 31, 2013 | 1.97% |
| Dec 31, 2012 | 70.54% |
| Sep 30, 2012 | -2.45% |
| Jun 30, 2012 | -2.39% |
| Mar 31, 2012 | -2.33% |
| Dec 31, 2011 | -2.28% |
| Sep 30, 2011 | -2.69% |